Initiating coverage on Unicycive Therapeutics, Inc. with a Buy rating and $6 price target, as the recent FDA CRL is manufacturing-related and resolvable. OLC's ultra-low pill burden and strong patient preference position it for significant market share in the $2.7B phosphate binder market for dialysis patients. DCF valuation supports attractive upside even with conservative 20% peak market share, with backup manufacturing in place and 80% historical CRL resolution rate.
Commercial Metals (CMC) reported earnings 30 days ago. What's next for the stock?
Vietnam's tech firm CMC Corp. has got approval from the authorities of Ho Chi Minh City to build a $250-million hyperscale data centre there, it said on Monday.
Commercial Metals Company (NYSE:CMC ) Q3 2025 Earnings Conference Call June 23, 2025 11:00 AM ET Company Participants Paul J. Lawrence - Senior VP & CFO Peter R.
The headline numbers for Commercial Metals (CMC) give insight into how the company performed in the quarter ended May 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Commercial Metals (CMC) came out with quarterly earnings of $0.74 per share, missing the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $1.02 per share a year ago.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Commercial Metals (CMC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended May 2025.
Commercial Metals (CMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CMC benefits from infrastructure tailwinds and efficiency gains, but macroeconomic and tariff uncertainties warrant caution before investing. Recent results show resilient cost management and a growing project pipeline, supporting the thesis of structurally higher through-the-cycle margins. Tariffs may provide short-term margin boosts, but demand could suffer long-term, and CMC's European exposure and policy risks limit upside compared to peers like STLD.
I rate Commercial Metals Company as a Hold, given a balanced risk/reward profile and current valuation reflecting only modest growth expectations. Strong industry tailwinds exist from infrastructure spending, reshoring, and green construction, but regime uncertainty and tariff risks temper demand visibility. CMC's 100% EAF production, vertical integration, and management alignment support long-term value, yet recent financial performance has deteriorated since 2022.
CMC expects its fiscal third-quarter results to rebound from the second-quarter reported levels.
Commercial Metals Company (NYSE:CMC ) Q2 2025 Earnings Conference Call March 20, 2025 11:00 AM ET Company Participants Peter Matt - President and CEO Paul Lawrence - SVP and CFO Conference Call Participants Sathish Kasinathan - Bank of America Timna Tanners - Wolfe Research Mike Harris - Goldman Sachs Andrew Jones - UBS Operator Hello, and welcome, everyone, to the Fiscal 2025 Second Quarter Earnings Call for CMC. Joining me today on today's call are Peter Matt, CMC's President and Chief Executive Officer; and Mr.